MULTIVALENT FIBRONECTIN-INTEGRIN BINDING COMPOSITIONS AND METHODS OF USE THEREOF
First Claim
Patent Images
1. A peptide composition comprising a peptide of an amino acid sequence selected from the group consisting of SEQ ID NOs.:
- 1-41, a combination of any of those sequences, a substantial fragment thereof, or a pharmaceutically acceptable salt thereof.
1 Assignment
0 Petitions
Accused Products
Abstract
The invention provides multivalent fibronectin-integrin binding compositions and methods of use thereof. In certain embodiments, the invention provides peptide compositions that include at least two fibronectin binding peptides coupled together as a cancer therapeutic or a diagnostic tool.
1 Citation
14 Claims
-
1. A peptide composition comprising a peptide of an amino acid sequence selected from the group consisting of SEQ ID NOs.:
- 1-41, a combination of any of those sequences, a substantial fragment thereof, or a pharmaceutically acceptable salt thereof.
- View Dependent Claims (2, 3, 4, 5, 6, 7, 9, 10, 11)
-
8. A method for targeting or identifying cancer cells wherein cancerous cells express a component that may be bound by fibronectin/integrin binding peptides, the method comprising the step of administering to a subject of a peptide composition comprising a peptide of an amino acid sequence selected from the group consisting of SEQ ID NOs.:
- 1-41, a combination of any of those sequences, or a substantial fragment thereof, wherein a label for identification is coupled to the peptide composition.
-
12. A method for treating a cancer wherein cancerous cells express a component that may be bound by fibronectin/integrin binding peptides, the method comprising the step of administering to a patient of said cancer therapeutically effective amount of a peptide composition comprising a peptide of an amino acid sequence selected from the group consisting of SEQ ID NOs.:
- 1-41 or a combination of any of those sequences, wherein an anti-cancer agent is coupled to the peptide composition.
- View Dependent Claims (13, 14)
Specification